Quantcast

Kershaw, Cutter & Ratinoff Launches New Website with Information on Cobaltism, Metallosis, Cobalt & Chromium Toxicity

March 26, 2011

Hip replacement recall lawyers hired renowned metal toxicology expert to answer questions about elevated cobalt and chromium blood levels caused by the recalled DePuy ASR metal-on-metal hip replacement device.

Sacramento, CA (Vocus/PRWEB) March 25, 2011

Today, Kershaw, Cutter & Ratinoff announced the launch of a new website designed to provide up-to-date scientific information about cobalt and chromium toxicity to victims of the recent DePuy hip implant recall. Last August, DePuy announced the recall of approximately 90,000 prosthetic hips when it was discovered that these hips were releasing small metal particles into the individuals in whom they were implanted. As a result, many individuals with these hips were found to have highly elevated levels of cobalt and chromium in their blood, which were emanated from the metals used to manufacture the hip.

Unfortunately, DePuy Orthopedics has provided little guidance as to what patients whose hips are otherwise working properly should do if they are found to have elevated blood levels of cobalt and chromium. This is because there is little information available to the public concerning cobaltism, metallosis, and the long term health consequences of being exposed to high levels of cobalt and chromium. The website attempts to answer many questions that are plaguing people with these hips.

Kershaw Cutter partner Stuart Talley explained, “We represent more than 100 individuals who believe they have a recalled hip, and most have been shown to have elevated levels of cobalt and chromium in their blood. Unfortunately, there seems to be a lot of confusion in the medical community as to what to do about this situation. Some of our clients’ doctors are removing the prosthetic hips even when cobalt levels are slightly elevated, while others are taking a ‘wait and see’ approach. The worst part for our clients who still have these hips is the fear of the unknown. They want to know what elevated levels of cobalt and chromium will do to them. This is why we put this website together.”

The centerpiece of the website is an extensive two hour video interview with Dr. Michael McCabe, one of the world’s leading scientists in the area of metal toxicity. The interview is broken down into short segments that attempt to answer specific questions that have commonly been raised by hip replacement patients. For example, Dr. McCabe discusses the studies that have been conducted to determine the long term affects of cobalt and chromium toxicity, what is the “normal” level of cobalt in the body, and what potential health risks should patients with these hips be aware of going forward.

Additionally, the website has an extensive library of more than fifteen medical journal articles that specifically address cobalt and chromium toxicity and the issues with the DePuy hip. This library will be regularly updated as new research is published.

“We believe that knowledge is power, and patients with these hips should know as much as possible about the risks they face going forward. We spent a lot of time putting the site together and hope it will help people obtain the knowledge they need to make the right decisions,” said Talley.

Kershaw, Cutter & Ratinoff have demonstrated their dedication to protecting the legal rights of patients affected by medical device recalls, as well as their ability to devote substantial resources through trials involving large corporations. Their insurance lawyers have helped California physicians recover disability insurance bad faith claims and their class action and personal injury lawyers have represented thousands of victims of defective medical devices, dangerous drugs and consumer products in cases throughout the United States. They have generated millions of dollars in lawsuit recoveries for their clients and the classes they have represented.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebcobalt-chromium-toxicity/metallosis/prweb8239067.htm


Source: prweb



comments powered by Disqus